Riskpilot← Back to searchSign inGet full accessSTAVANGER SPECSAVERS AS
ASActiveOrg 995498448Kirkegata 24, 4006 StavangerRetail sale of medical and orthopaedic goods · NACE 4774Est. 201011 employees
Revenue 2024
NOK 11,9M
+3% vs 2023
EBITDA margin
0.1%
-95% vs 2023
Equity ratio
-30.2%
Financial strength
Net profit 2024
NOK -7K
-105% vs 2023
| Revenue | NOK 11,9M | +3% |
| EBITDA | NOK 9K | -95% |
| Net profit | NOK -7K | -105% |
| Total assets | NOK 1,1M | -2% |
| Equity | NOK -328K | -2% |
| Employees | 11 | — |
Legal name
STAVANGER SPECSAVERS AS
Org number
995498448
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
10. mai 2010
Share capital
NOK 30 125
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Handel med optiske varer samt det som naturlig står i forbindelse med dette.
Address
Kirkegata 24, 4006 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 6 278 | 6 602 | 8 532 | 9 129 | 9 440 | 9 690 | 10 894 | 12 685 | 10 243 | 9 200 | 10 847 | 11 798 | 11 546 | 11 943 |
| Staff expenses | −9 | −1 864 | −2 420 | −2 542 | −2 841 | −2 934 | −3 005 | −3 408 | −4 007 | −3 863 | −2 968 | −3 300 | −3 702 | −3 598 | −3 857 |
| EBITDA | −78 | 67 | −291 | 585 | 611 | 506 | 436 | 631 | 1 074 | −461 | 143 | 250 | 398 | 183 | 9 |
| Depreciation & amort. | −14 | −298 | −314 | −314 | −295 | −266 | −73 | −307 | −343 | −343 | −336 | −297 | −58 | −41 | −16 |
| EBIT | −92 | −231 | −605 | 271 | 315 | 240 | 363 | 324 | 732 | −804 | −193 | −47 | 340 | 142 | −7 |
| Net financials | 0 | −67 | −93 | −66 | −46 | −23 | −20 | −68 | −53 | −42 | −28 | −13 | −1 | −4 | 0 |
| Profit before tax | −92 | −298 | −698 | 204 | 270 | 217 | 344 | 257 | 678 | −845 | −221 | −61 | 339 | 138 | −7 |
| Tax | −26 | 26 | −0 | −0 | −0 | −0 | 19 | 59 | 175 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −66 | −324 | −698 | 204 | 270 | 217 | 325 | 198 | 503 | −845 | −221 | −61 | 339 | 138 | −7 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 382 | 4 236 | 1 820 | 1 290 | 1 139 | 1 115 | 2 424 | 2 746 | 2 990 | 1 224 | 998 | 543 | 845 | 1 103 | 1 084 |
| Equity | 34 | −290 | −988 | −784 | −514 | −297 | 28 | 226 | 329 | −516 | −737 | −798 | −459 | −321 | −328 |
| Long-term debt | 191 | 2 202 | 1 524 | 1 126 | 728 | 329 | 1 376 | 1 019 | 759 | 498 | 303 | 43 | 0 | 0 | 0 |
| Short-term debt | 1 157 | 2 323 | 1 284 | 948 | 926 | 1 083 | 1 020 | 1 501 | 1 902 | 1 241 | 1 432 | 1 297 | 1 304 | 1 424 | 1 411 |
| Total debt | 1 348 | 4 526 | 2 808 | 2 074 | 1 653 | 1 412 | 2 396 | 2 520 | 2 661 | 1 740 | 1 736 | 1 341 | 1 304 | 1 424 | 1 411 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20102024
Equity ratio
-30.2%
This company
38.2%
Market median
-179% vs market
20102024
Return on equity
-661600.0%
This company
18.4%
Market median
-3595752% vs market
20102024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20102024
Asset turnover
11.02×
This company
1.12×
Market median
+884% vs market
20102024
Debt / equity
4.31×
This company
0.62×
Market median
-595% vs market
20102024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EG Deputy Member | Deputy Member | 2018 | — | — |
TA Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
ET Deputy Member | Deputy Member | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STAVANGER SPECSAVERS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erlend Goa | Deputy Member | 0 companies |
| Trine Aasland Sekkesæter | Chief Executive Officer | 0 companies |
| Erlend Tønnessen Goa | Deputy Member | 0 companies |
| Richard Neil Owens | Chairman | 0 companies |
| Erik Wøllo | Board of Directors | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |
| Nina Helen Kleppe | Board of Directors | 0 companies |
| Erle Hortense Veim Ohm | Board of Directors | 0 companies |